MedCity News February 1, 2024
Molly McGaughan and Kostja Paschalidis

The more pharma companies do to become service providers in the personalized medicine era, the more they’ll succeed and the more lives they’ll help to save.

Personalized medicine is quite possibly the greatest healthcare innovation of our time. It offers the chance to improve and even save the lives of millions of people. But it also presents challenges unlike anything the healthcare establishment has seen. It will take a new form of leadership — including, and especially, from pharmaceutical companies — to bring this innovation to the masses.

As the FDA puts it, precision medicine “is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people’s genes, environments, and lifestyles.” Its goal “is to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Precision Medicine
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article